跳至主要内容
临床试验/NCT01117402
NCT01117402Unknown2 期

Phase II Study Evaluating the Role of Tomotherapy- Based Intensity Modulated Radiotherapy and Brachytherapy in Postsurgery Recurrent Carcinoma Cervix

Tata Memorial Hospital2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2008年12月最近更新:
适应症

试验速览

阶段
2 期
入组人数
90
试验地点
2
主要终点
To evaluate the utility of intensity-modulated radiotherapy (IMRT) in delivering dose escalated radiotherapy in postoperative recurrent cases of carcinoma cervix, in terms of local control

研究概览

简要总结

Radiotherapy is the most appropriate treatment for postoperative recurrent carcinoma cervix. However it is technically difficult to deliver adequate doses of RT due to presence of small intestines in the radiation area; thus disease control rates are poor and complication rates are high with conventional radiotherapy. Use of IMRT and brachytherapy for these cases allows for increasing dose to the tumor while sparing normal structures. It is expected that the use of a combination of IMRT & brachytherapy will achieve higher disease control rates and decrease the complication rates.

详细描述

SPECIFIC OBJECTIVES:

  1. To evaluate the efficacy of combination of intensity-modulated radiotherapy (IMRT) and brachytherapy in delivering dose escalated radiotherapy in postoperative residual / recurrent cases of carcinoma cervix, in terms of local control proportion and progression free survival (PFS)
  2. To study the late and acute toxicities associated with this treatment.
  3. Dosimetric comparison of Tomotherapy and conventional IMRT

DESIGN: Prospective, phase II study.

STUDY POPULATION: All patients of age < 65 years diagnosed with postsurgery recurrent squamous cell carcinoma cervix without previous history of radiotherapy.

STUDY SIZE: 90 patients

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • . Only histologically proven postoperative recurrence of squamous carcinoma of cervix following hysterectomy >3 months without adjuvant treatment
  • Patients below 65 years of age and with KPS >70%.
  • Patients with disease confined to the pelvis, based on CT/MRI/PET Scan
  • Normal ECG and cardiovascular system
  • Normal hematological parameters
  • Normal renal and liver function tests

排除标准

  • Previous chemotherapy or radiotherapy to the pelvis
  • Pelvic LN >3cm in size
  • Presence of disease outside the pelvis (Paraortic nodes, distant metastasis)
  • Bilateral hydronephrosis
  • Co-morbid conditions like uncontrolled Diabetes Mellitus or medical renal disease
  • Medical or Psychological condition that would preclude treatment
  • Patient unreliable for treatment and follow-up.

结局指标

主要结局

To evaluate the utility of intensity-modulated radiotherapy (IMRT) in delivering dose escalated radiotherapy in postoperative recurrent cases of carcinoma cervix, in terms of local control

时间窗: 3 Years

Progression free survival of all patients

次要结局

  • To study the late toxicities associated with this treatment(3 Years)

研究者

申办方类型
Other Gov

研究点 (2)

Loading locations...

相似试验

Tomotherapy in Postsurgery Recurrent Carcinoma Cervix | 临床试验